Synthetic-CT training patients
244 patients
- EndpointMR-to-synthetic-CT dataset
- PopulationMRI Planner
- Tested versionMRI Planner
FDA-cleared profile
Spectronic Medical AB · Radiotherapy Planning Imaging · FDA-cleared (510(k))
Authorized purpose: MRI Planner creates synthetic CT images for photon external-beam radiation planning from MRI and can generate healthy-structure contours for specified brain, head-and-neck, and pelvic workflows; it is not intended to contour tumors or clinical target volumes.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: MRI Planner creates synthetic CT images for photon external-beam radiation planning from MRI and can generate healthy-structure contours for specified brain, head-and-neck, and pelvic workflows; it is not intended to contour tumors or clinical target volumes.
Evidence takeaway. Evidence from the reviewed source record: K211841 reports 244 MR/CT patients for synthetic CT development and 175 MR patients for prostate contours. Dose testing included 58 pelvic and 75 brain or head-and-neck patients, with average dose differences near zero and high-dose gamma averages of 99.8% to 99.9%; auto-contour Dice values were 0.95 for bladder, 0.90 for colon, and 0.96 for femoral heads in 51 patients.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
The exact device description supports a DICOM MR image-stack input; patient metadata and release-specific planning inputs are not stated.
The exact device description supports synthetic CT and contour outputs and describes contours as a starting point for manual delineation; it does not state approval or session-management wording.
The exact indications name these trained users and do not name radiation therapists.
The exact packet provides the tumor/CTV and display/storage boundaries and the instruction to use existing radiotherapy-planning software; qualified final approval wording is not stated.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Sensitivity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
Specificity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
244 patients
58 patients
75 patients
0.02 %
99.9 %
0.95 coefficient
0.9 coefficient
0.96 coefficient
K211841
Manufacturer evidence submitted for FDA clearance or approval; local clinical, technical, and workflow acceptance remains necessary.
3 unlinked candidate evidence records are retained for source review and excluded from this evidence display.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Exact-identifier review does not prove absence of all product-family safety signals.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
No separate named-product payment identified in reviewed public material
Centers for Medicare & Medicaid Services · United StatesBuild a local total-cost and value model; do not infer reimbursement from FDA clearance or approval.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Based on a DICOM MR image stack, the software generates synthetic CT images and generates contours of anatomical structures in the MR image stack.
Scope: Exact FDA submission. The exact device description supports a DICOM MR image-stack input; patient metadata and release-specific planning inputs are not stated.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-19 · FDA K211841: MRI Planner
Source context, not route validation: DICOM MRI, synthetic CT, RTSTRUCT, and planning-system exchange; validate registration, patient identity, geometry, density assignment, dose, and export.
Scope: Product family. Current vendor materials are product-family evidence for K211841; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-03 · FDA K211841: MRI Planner · Spectronic MRI Planner
Source context, not route validation: Release-specific clinical software deployed on a workstation or server within the radiation-oncology network.
Scope: Product family. Current vendor materials are product-family evidence for K211841; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-03 · FDA K211841: MRI Planner · Spectronic MRI Planner
Source context, not route validation: The software generates synthetic CT images that can be used for attenuation calculations in radiotherapy treatment planning and generates contours of anatomical structures in the MR image stack, to be used as a starting point for the manual delineation work required in radiotherapy treatment planning.
Scope: Exact FDA submission. The exact device description supports synthetic CT and contour outputs and describes contours as a starting point for manual delineation; it does not state approval or session-management wording.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-19 · FDA K211841: MRI Planner
Unresolved route: The software generates synthetic CT images that can be used for attenuation calculations in radiotherapy treatment planning and generates contours of anatomical structures in the MR image stack, to be used as a starting point for the manual delineation work required in radiotherapy treatment planning.
Scope: Exact FDA submission. The exact device description supports synthetic CT and contour outputs and describes contours as a starting point for manual delineation; it does not state approval or session-management wording.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-19 · FDA K211841: MRI Planner
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Current vendor materials are product-family evidence for K211841; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Current vendor materials are product-family evidence for K211841; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Current vendor materials are product-family evidence for K211841; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Map the installed model, build, options, population, anatomy, inputs, outputs, and enabled AI functions to K211841 before acceptance.
exact submission · checked 2026-09-03Later product-family features are not evidence that this cleared release includes them.
DICOM MRI, synthetic CT, RTSTRUCT, and planning-system exchange; validate registration, patient identity, geometry, density assignment, dose, and export.
product family · checked 2026-09-03Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally. Vendor statements are current product-family context; confirm the exact cleared release and installed options.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Synthetic CT and auto-contours are limited to labeled anatomy and structures and are not tumor or clinical-target-volume delineation; qualified staff must verify images, contours, dose, and plans before treatment.
exact submission · checked 2026-09-03Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03No exact-product price was found in the reviewed public material; vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Synthetic CT and auto-contours are limited to labeled anatomy and structures and are not tumor or clinical-target-volume delineation; qualified staff must verify images, contours, dose, and plans before treatment.
product family · checked 2026-09-03Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. Vendor statements are current product-family context; confirm the exact cleared release and installed options.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
The exact indications establish brain, head-neck, pelvis, and the prostate-patient bladder, colon, and femoral-head contour scope; the current brain-only anatomy is too narrow. Controlled directory display reconciled from exact FDA wording: MRI Planner is indicated for radiotherapy planning of adult patients for primary and metastatic cancers in the brain and head-neck regions, as well as soft tissue cancers in the pelvic region. MRI Planner generates synthetic CT images for radiation attenuation estimation purposes for the pelvis, brain and head-neck regions only. MRI Planner generates automatically derived contours of the bladder, colon and femoral heads, for prostate cancer patients only. -> Brain.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The refreshed discovery snapshot contains 6 PubMed and 0 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 6 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda decision material, vendor product page, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
13 sources - 3 history items
Scope: purpose, modality, evidenceSummary, anatomy, intendedUsers, input, output, limitations, clinicalUse
Scope: regulatoryIdentity, modalityContext
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: reimbursement, radiationTherapyPaymentContext
Scope: productFamilyContext, workflowRole, implementationCapabilities
Scope: evidenceStudies, productFamilyContext, evidenceDiscovery
Scope: evidenceStudies, productFamilyContext, evidenceDiscovery
Scope: evidenceStudies, productFamilyContext, evidenceDiscovery
Scope: evidenceStudies, productFamilyContext, evidenceDiscovery
Scope: evidenceStudies, productFamilyContext, evidenceDiscovery
Scope: evidenceStudies, productFamilyContext, evidenceDiscovery
Regulatory record
510(k)
Research record
fda record reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Philips Medical Systems MR Finland
Generation of MR-derived attenuation information for photon radiotherapy planning of primary and metastatic brain tumors.
Aitewan Biomedical Technology, Inc.
Authorized purpose: DeepBT Detector-Plus provides initial gross-tumor-volume contours on T1-weighted contrast-enhanced and optional T2-weighted MR images for radiation-treatment planning in adults with the labeled brain tumors.
Varian Medical Systems, Inc.
Authorized purpose: syngo.via RT Image Suite VC10 provides three-dimensional and four-dimensional multimodality visualization, registration, fusion, contouring, and planning support for radiation-treatment preparation.
Elekta Solutions AB
Authorized purpose: The EMLA family delivers external-beam radiation therapy for adult and pediatric patients with benign, malignant, or metastatic disease. Authorized techniques vary by model: Synergy and Harmony include conventional and fractionated delivery; Infinity and Harmony Pro add SBRT/SABR; Versa HD and Evo also support SRS and specified functional disorders.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history